Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05826925 · ClinicalTrials.gov registry record · NA

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

A NA study of Cardiovascular Diseases and Preeclampsia, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05826925 is a NA study of Cardiovascular Diseases and Preeclampsia that is actively recruiting participants, run by University of Utah. The registered enrollment target is 30 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05826925, a NA study of Cardiovascular Diseases and Preeclampsia, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.

Interventions

  • OTHER Decision aid

Study Locations (1)

Utah

  • University of Utah Hospital - Salt Lake City

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-02-27
Est. Completion 2027-08
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT05826925

The ClinicalTrials.gov registry entry for NCT05826925 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Decision aid is the first listed.

NCT05826925 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT05826925 about?

NCT05826925 is a clinical study titled "Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy". Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered...

What is the current status of trial NCT05826925?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-02-27. Estimated completion is 2027-08.

What conditions does trial NCT05826925 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Preeclampsia, Hypertension, Pregnancy Induced, Patient Engagement, Hypertension Complicating Pregnancy.

What interventions are being tested in trial NCT05826925?

The interventions under investigation include: Decision aid (OTHER).

Who is sponsoring clinical trial NCT05826925?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05826925 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.